Simon is a hi tech entrepreneur and investor with a focus on AI and healthcare technology. Co-founder of 7 venture backed companies, including Deep Lens, Predixion Software and Versifi, which together raised over $100M in venture backing. All three were acquired.

Co-founder/Chair/CEO: ChromaCode (COVID XPrize winner); Helixis (acquired by Illumina) and Luxtera (acquired by Cisco). Board member Gencove (low pass sequencing) and previously PRA Health Sciences (public, acquired by ICON). Seven year Illumina SVP (led BaseSpace and PopSeq businesses). Began career in research at Bell Labs; co-inventor of the CMOS fingerprint sensor.

Alex Verbitsky leads the AI and Data Science team at Ryght, building agentic production systems that accelerate clinical trials. With over eight years of experience spanning startups, government, and pharmaceutical companies, he has shipped multimodal AI systems for trial operations, document processing, data harmonization, and diagnostic imaging. Author of 10+ publications bridging AI and biomedicine, Alex holds an M.S. in Computer Science from Georgia Tech and a B.S. in Biomedical Engineering from Penn State.

Stephanie is the VP of Clinical Operations at Ryght. She has more than 20 years of clinical operations experience, specializing in study start-up, feasibility, and site selection, with a concentration in oncology/hematology and rare disease. She has worked at pharmaceutical companies and CROs, and as a Program Oversight Director at a biotech company, overseeing CRO partners and clinical program delivery. 

Sara Dada is an experienced Product Management professional based in the San Francisco Bay Area. She has previously served on the product team of a B2B SaaS company, consulted for various startups, and worked as a data analyst for a venture fund. She studied Business Administration and Technology Ethics at Cal Poly SLO.

As Director of Business Development, Dylan leads Ryght’s efforts to build relationships with customers and generate new business. Coming from the CRO space, at IQVIA Biotech, he understands the needs of biotech clients as well as the nuances of the clinical trial landscape. Dylan studied Business Administration and International Affairs at the University of North Carolina Wilmington and still calls Wilmington his home. When he is not working, you can find him at the pickleball courts, on the golf course, traveling the world, or spending time with his family.

Tom Pike is a seasoned global leader with more than 30 years of experience across the business services, healthcare, and technology industries. He currently serves as President and Chief Executive Officer of Labcorp's Clinical Development business, which has been announced to spin out from Labcorp as an independent company, where Tom will serve as Chairman and Chief Executive Officer.

Throughout his career, Tom has built a distinguished record of creating value and driving growth across complex, regulated, and fast-moving environments. His expertise spans global strategy and operations, with deep knowledge across the contract research organization (CRO) industry, working alongside pharmaceutical and biotech companies, hospitals, and clinical sites on a worldwide scale. He brings a compelling ability to combine visionary strategy with disciplined execution, resulting in consistent outcomes in both revenue growth and margin improvement.

Tom's professional foundation was shaped by his time at world-renowned firms including Accenture and McKinsey, where he gained broad exposure to industries such as retail and manufacturing. These experiences, combined with focused work across pharma, payers, and providers, have equipped him with an extensive toolkit of strategies, relationships, and insights that he applies to identifying and addressing the most pressing challenges and opportunities facing organizations today.

A recognized thought leader and public speaker, Tom has shared his perspectives on management, pharmaceutical research, and industry trends at numerous conferences and in a wide range of media, including print, television, and multiple appearances on CNBC's Mad Money with Jim Cramer.

Driven by a customer-first philosophy, Tom remains committed to leveraging his experience to create lasting value for customers, employees, shareholders, and stakeholders alike.

Tarek Sherif, former CEO and co-founder, Medidata Solutions & Ryght Advisor, co-founded Medidata Solutions in 1999, where he played a pivotal role in transforming clinical research by automating and digitizing trials through cloud-based solutions. Under his leadership, Medidata became the industry standard for clinical trial data management and analytics, by delivering leading edge technology along with customer centric services.  

Sherif brings a wealth of experience and a proven track record in pioneering cloud-based solutions and automating clinical trials.

Kent Siri is an accomplished B2B healthcare marketing leader with deep expertise in building standout brands, driving growth strategies, and developing high-performing teams. He currently serves as Vice President of Marketing at ZenQMS, where he helps life sciences companies streamline quality management with scalable SaaS solutions. Previously, Kent held senior marketing leadership roles at Reify Health, Medidata, SHYFT Analytics, and Kyruus, where he built brand foundations, led demand generation, and partnered with top life sciences organizations. He is passionate about creating customer-focused strategies that deliver measurable business impact. 

Craig brings more than 24 years of experience in clinical development, data operations, and technology transformation across Pfizer, Novartis, Flatiron Health, IQVIA, and Amgen.

He has built global functions, scaled clinical research businesses, and led initiatives spanning hundreds of studies and thousands of users. His work includes designing new Data Management and Clinical Systems functions at Amgen, growing Flatiron Health’s commercial clinical research business, and advancing AI-enabled operations at Novartis.

As a strategic advisor to Ryght, Craig brings insight into both pharmaceutical operations and commercial healthtech, helping connect technology innovation with the practical needs of clinical research teams.